We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$812B
AUM Growth
-$55.8B
Cap. Flow
-$18.8B
Cap. Flow %
-2.31%
Top 10 Hldgs %
32.22%
Holding
3,109
New
91
Increased
2,002
Reduced
738
Closed
70

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$3.81B
2
XYZ
Block Inc
XYZ
+$1.46B
3
ACN icon
Accenture
ACN
+$1.23B
4
GILD icon
Gilead Sciences
GILD
+$1.15B
5
VLO icon
Valero Energy
VLO
+$1.05B

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.61B
2
META icon
Meta Platforms (Facebook)
META
+$2.06B
3
TSLA icon
Tesla
TSLA
+$1.81B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.72B
5
AMZN icon
Amazon
AMZN
+$1.59B

Sector Composition

Rank Sector Weight
1 Technology 30.44%
2 Healthcare 13.92%
3 Financials 12.3%
4 Consumer Discretionary 10.98%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCHP icon
501
Microchip Technology
MCHP
$43.3B
$137M 0.02%
2,824,213
+296,379
+12% +$16.5M
MP icon
502
MP Materials
MP
$9.83B
$136M 0.02%
5,589,268
-948,243
-15% -$22M
SARO
503
StandardAero Inc
SARO
$8.99B
$136M 0.02%
5,115,657
-1,177,869
-19% -$31.4M
AXON
504
Axon Enterprise
AXON
$49.1B
$136M 0.02%
258,471
-21,016
-8% -$12.3M
COPX icon
505
Global X Copper Miners ETF NEW
COPX
$7.97B
$135M 0.02%
3,462,776
-26,584
-0.8% -$1.06M
ETR icon
506
Entergy
ETR
$49.9B
$135M 0.02%
1,576,403
-461,601
-23% -$38M
ZTO icon
507
ZTO Express
ZTO
$17.4B
$134M 0.02%
6,772,015
+149,522
+2% +$2.92M
PCVX icon
508
Vaxcyte
PCVX
$8.87B
$134M 0.02%
3,542,007
-424,949
-11% -$34M
VFC icon
509
VF Corp
VFC
$5.81B
$132M 0.02%
8,534,676
-5,148,154
-38% -$114M
BAP icon
510
Credicorp
BAP
$30.1B
$132M 0.02%
708,582
-48,689
-6% -$9.04M
CFLT
511
DELISTED
Confluent
CFLT
$129M 0.02%
5,510,743
+654,827
+13% +$19M
TMSL icon
512
T. Rowe Price Small-Mid Cap ETF
TMSL
$2.93B
$127M 0.02%
+4,169,160
New +$135M
TPG icon
513
TPG
TPG
$8.41B
$127M 0.02%
2,669,590
+416,520
+18% +$24.3M
SMMT icon
514
Summit Therapeutics
SMMT
$11.7B
$127M 0.02%
6,557,804
-123
-0% -$2.47K
AMCR icon
515
Amcor
AMCR
$21.5B
$123M 0.02%
2,528,730
+30,205
+1% +$1.49M
DFS
516
DELISTED
Discover Financial Services
DFS
$123M 0.02%
717,833
+192,447
+37% +$35.2M
KIM icon
517
Kimco Realty
KIM
$16.3B
$122M 0.02%
5,733,286
-573,123
-9% -$12.5M
ACLX
518
DELISTED
Arcellx
ACLX
$121M 0.01%
1,839,624
-281,698
-13% -$19.1M
VRNA
519
DELISTED
Verona Pharma
VRNA
$118M 0.01%
1,866,280
+32,748
+2% +$1.96M
RYAAY icon
520
Ryanair
RYAAY
$30.8B
$118M 0.01%
+2,786,653
New +$127M
ARMK icon
521
Aramark
ARMK
$16.2B
$117M 0.01%
3,397,158
-707,173
-17% -$26M
RARE icon
522
Ultragenyx Pharmaceutical
RARE
$2.62B
$117M 0.01%
3,218,942
+706,519
+28% +$29.4M
HOOD icon
523
Robinhood
HOOD
$88.5B
$116M 0.01%
2,796,075
-2,389,150
-46% -$114M
PAYX icon
524
Paychex
PAYX
$43.4B
$116M 0.01%
753,450
+17,522
+2% +$2.58M
MLTX icon
525
MoonLake Immunotherapeutics
MLTX
$1.42B
$116M 0.01%
2,973,830
-369,813
-11% -$15.9M

Similar funds

T. Rowe Price Associates's Q1 2025 Portfolio in Review

As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
  • T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
  • T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
  • T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
  • T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
  • T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.

Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.